Recently, Brandes et al. [69] described molecular mechanisms of Nox activation and supported their implications in diabetes, hyperglycemia, and hyperinsulinemia through complex pathways involving NADPH oxidases. This evidence concerns the gene FMO5 and Hyperglycemia.